AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10598302 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with milnacipran
Number of subjects: 0
Study 10598302 — intervention group
Group type: COMPARATOR
Intervention: Episodic treatment
Number of subjects: 0
Study 7721386 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg/d)
Number of subjects: 25
Study 7721386 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 to 100 mg/d)
Number of subjects: 25
Study 1974271 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Release (CR) 200 mg, administered b.i.d.
Number of subjects: 13
Study 1974271 — intervention group
Group type: COMPARATOR
Intervention: Immediate Release (IR) 200 mg, administered b.i.d.
Number of subjects: 13
Study 6119509 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 32
Study 6119509 — intervention group
Group type: COMPARATOR
Intervention: Unchanged conventional treatment (UCT)
Number of subjects: 32
Study 31887537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 658
Study 28742225 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 448
Study 28742225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study 27670138 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised approach bias modification (10 sessions)
Number of subjects: 54
Study 27670138 — intervention group
Group type: COMPARATOR
Intervention: Sham training (control condition)
Number of subjects: 54
Study 27670138 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised approach bias modification
Number of subjects: 54
Study 24290406 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter modified acetylcysteine regimen (12 h)
Number of subjects: 222
Study 24290406 — intervention group
Group type: COMPARATOR
Intervention: Standard acetylcysteine regimen (20.25 h)
Number of subjects: 222
Study 24290406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron pretreatment (4 mg)
Number of subjects: 222
Study 24290406 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no antiemetic pretreatment)
Number of subjects: 222
Study 22935043 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 25
Study 22935043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 20541000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutanova Nanorepair Q10 cream
Number of subjects: 0
Study 20541000 — intervention group
Group type: COMPARATOR
Intervention: NLC negative control cream
Number of subjects: 0
Study 18085432 — intervention group
Group type: EXPERIMENTAL
Intervention: Directly administered antiretroviral therapy (DAART)
Number of subjects: 141
Study 18085432 — intervention group
Group type: COMPARATOR
Intervention: Self‐administered therapy (SAT)
Number of subjects: 141
Study 16157524 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting myocardial perfusion heterogeneity quantified by Markovian homogeneity analysis
Number of subjects: 1084
Study 16157524 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement during dipyridamole stress
Number of subjects: 1084
Study 16157524 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting homogeneity index outside 1 SD of healthy reference subjects
Number of subjects: 1084
Study 16157524 — intervention group
Group type: COMPARATOR
Intervention: Standard risk factors
Number of subjects: 1084
Study 12611611 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium status
Number of subjects: 1900
Study 12611611 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 1900
Study 10960901 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage with essential oils (aromatherapy)
Number of subjects: 8
Study 10960901 — intervention group
Group type: COMPARATOR
Intervention: Massage only (control group)
Number of subjects: 8
Study 8750423 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentions regarding sexual intercourse in the next half-year
Number of subjects: 119
Study 8750423 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth who thought it likely they would be sexually-active in the next 6 months
Number of subjects: 119
Study 8750423 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentions regarding future coitus among sexually-experienced youth at baseline
Number of subjects: 119
Study 1408571 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antimicrobial agents
Number of subjects: 279
Study 1408571 — intervention group
Group type: COMPARATOR
Intervention: Parenteral antibiotics
Number of subjects: 279
Study 1408571 — intervention group
Group type: EXPERIMENTAL
Intervention: Change from parenteral to oral antibiotics
Number of subjects: 279
Study 1408571 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 279
Study 3913756 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (75-300 micrograms daily)
Number of subjects: 59
Study 3913756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 3578614 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management services (E group, N = 213)
Number of subjects: 417
Study 3578614 — intervention group
Group type: COMPARATOR
Intervention: Usual and customary services (C group, N = 204)
Number of subjects: 417
Study 29392280 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFields therapy
Number of subjects: 695
Study 29392280 — intervention group
Group type: COMPARATOR
Intervention: Temozolomide alone
Number of subjects: 695
Study 27059152 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 351
Study 27059152 — intervention group
Group type: EXPERIMENTAL
Intervention: Open repair
Number of subjects: 351
Study 27059152 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 351
Study 24938404 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning cortisol levels
Number of subjects: 0
Study 24938404 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian modulation
Number of subjects: 0
Study 23422605 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (500 mg)
Number of subjects: 40
Study 23422605 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (325 mg)
Number of subjects: 40
Study 23422605 — intervention group
Group type: COMPARATOR
Intervention: Calcium vs Acetaminophen
Number of subjects: 40
Study 23422605 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium
Number of subjects: 40
Study 23422605 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 40
Study 23422605 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 20389249 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (2.4 g)
Number of subjects: 563
Study 20389249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 563
Study 17968030 — intervention group
Group type: EXPERIMENTAL
Intervention: special education program (clinical index group)
Number of subjects: 60
Study 17968030 — intervention group
Group type: COMPARATOR
Intervention: follow‐up without the special education program (clinical comparison group)
Number of subjects: 60
Study 16179955 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptin DPI (20 mcg)
Number of subjects: 16
Study 16179955 — intervention group
Group type: COMPARATOR
Intervention: Meptin MDI (20 mcg)
Number of subjects: 16
Study 12543895 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiocephalic AVF creation with surgical and interventional treatment
Number of subjects: 43
Study 12543895 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions (PTA and surgery) for non-functioning RCAVFs
Number of subjects: 43
Study 12543895 — intervention group
Group type: EXPERIMENTAL
Intervention: Functioning AVFs blood flow measurement
Number of subjects: 43
Study 12543895 — intervention group
Group type: EXPERIMENTAL
Intervention: Final functional status of RCAVFs
Number of subjects: 43
Study 10869893 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Lipofundin MCT/LCT (1.5 g. kg. d)
Number of subjects: 38
Study 10869893 — intervention group
Group type: COMPARATOR
Intervention: 10% LCT (1.5 g. kg. d)
Number of subjects: 38
Study 8937319 — intervention group
Group type: COMPARATOR
Intervention: Conventional spin-echo (CSE)
Number of subjects: 29
Study 8937319 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast spin-echo (FSE)
Number of subjects: 29
Study 8937319 — intervention group
Group type: COMPARATOR
Intervention: Overall preference
Number of subjects: 29
Study 8937319 — intervention group
Group type: COMPARATOR
Intervention: Artefact level
Number of subjects: 29
Study 1547922 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic-acid-enriched diet (n = 16 after dropouts)
Number of subjects: 38
Study 1547922 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (n = 20)
Number of subjects: 38
Study 3157666 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (45 Gy)
Number of subjects: 138
Study 3157666 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (45 Gy)
Number of subjects: 138
Study 3157666 — intervention group
Group type: COMPARATOR
Intervention: Surgery only (Control)
Number of subjects: 138
Study 29059349 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic net proportional hazards regression model
Number of subjects: 92
Study 29059349 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward elimination model
Number of subjects: 92
Study 30573210 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium stored at room temperature
Number of subjects: 0
Study 30573210 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 26892713 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure CO2 pneumoperitoneum
Number of subjects: 50
Study 26892713 — intervention group
Group type: COMPARATOR
Intervention: Standard-pressure CO2 pneumoperitoneum
Number of subjects: 50
Study 25040325 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily application of a commercially available, standardised pH neutral, perfume-free moisturiser on extremities.
Number of subjects: 424
Study 25040325 — intervention group
Group type: COMPARATOR
Intervention: Ad hoc or no standardised skin-moisturising regimen (Control).
Number of subjects: 424
Study 25040325 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily application of moisturiser.
Number of subjects: 424
Study 21636189 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless wound closure
Number of subjects: 30
Study 21636189 — intervention group
Group type: COMPARATOR
Intervention: Multiple-suture closure
Number of subjects: 30
Study 20457972 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session pattern scanning laser panretinal photocoagulation (SS-PRP)
Number of subjects: 40
Study 20457972 — intervention group
Group type: COMPARATOR
Intervention: Multiple-session single-spot panretinal photocoagulation (MS-PRP)
Number of subjects: 40
Study 17661240 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD outpatient education programme (ATEM)
Number of subjects: 50
Study 17661240 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (control)
Number of subjects: 50
Study 16118757 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental walking training
Number of subjects: 24
Study 16118757 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 24
Study 12360554 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-10 mg/day to effect)
Number of subjects: 30
Study 12360554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11012909 — intervention group
Group type: EXPERIMENTAL
Intervention: RF-bic
Number of subjects: 117
Study 8831640 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational review group
Number of subjects: 0
Study 8831640 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session group
Number of subjects: 0
Study 8831640 — intervention group
Group type: COMPARATOR
Intervention: No review (single-session group)
Number of subjects: 0
Study 1575056 — intervention group
Group type: EXPERIMENTAL
Intervention: nHuIFN-alpha and nHuTNF-alpha combination (10 micrograms of nHuIFN-alpha and 3 micrograms of nHuTNF-alpha) injected intravenously at a maintenance dose of more than 2 x 10(6)U/day for over 8 weeks
Number of subjects: 120
Study 1575056 — intervention group
Group type: COMPARATOR
Intervention: nHuIFN-alpha and nHuTNF-alpha combination at a maintenance dose of 1 x 10(6)U/day
Number of subjects: 120
Study 3906426 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapride (600 mg/day)
Number of subjects: 21
Study 31889572 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing during IV cannulation
Number of subjects: 73
Study 31889572 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 73
Study 31228455 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (480 mg nanomicelle curcumin orally)
Number of subjects: 110
Study 31228455 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment only)
Number of subjects: 110
Study 29354951 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese medicine of artificial cycle therapy
Number of subjects: 60
Study 29354951 — intervention group
Group type: COMPARATOR
Intervention: Letrozole and metformin (control group)
Number of subjects: 60
Study 25391329 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention (6 feedback sessions with visual feedback during 2-point discrimination training and pelvic tilting)
Number of subjects: 30
Study 25391329 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 sessions of physiotherapy, relaxation training, and movement training)
Number of subjects: 30
Study 24219633 — intervention group
Group type: EXPERIMENTAL
Intervention: KUB&CT
Number of subjects: 154
Study 24219633 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 154
Study 21515027 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy (VRE)
Number of subjects: 41
Study 17698219 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized protocol for evaluation during phase II
Number of subjects: 1725
Study 17698219 — intervention group
Group type: COMPARATOR
Intervention: Control evaluation during phase II
Number of subjects: 1725
Study 16432600 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% tea lotion applied twice daily for 2 months
Number of subjects: 60
Study 16432600 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 60
Study 12891305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 90
Study 12891305 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 90
Study 12891305 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 90
Study 12891305 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving lipid lowering drugs)
Number of subjects: 90
Study 12891305 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 90
Study 10618570 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel readings by 3 experienced angiographers
Number of subjects: 308
Study 9252084 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 24
Study 9252084 — intervention group
Group type: COMPARATOR
Intervention: Elective sclerotherapy
Number of subjects: 24
Study 8302982 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine fading and cigarette fading
Number of subjects: 73
Study 8302982 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine fading and concurrent smokeholding
Number of subjects: 73
Study 8302982 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine fading and subsequent smokeholding
Number of subjects: 73
Study 8302982 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonintensive smokeholding programme
Number of subjects: 73
Study 8302982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive smokeholding programme (daily sessions)
Number of subjects: 73
Study 3574823 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg medroxyprogesterone acetate for days 1-28
Number of subjects: 3
Study 3574823 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg medroxyprogesterone acetate for days 1-28
Number of subjects: 3
Study 3574823 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg medroxyprogesterone acetate for days 17-28
Number of subjects: 3
Study 28144795 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.8-mm clear corneal incision
Number of subjects: 140
Study 28144795 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2-mm clear corneal incision
Number of subjects: 140
Study 28144795 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 140
Study 28508344 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 50
Study 28508344 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 50
Study 25679228 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention 'Mastery over Dementia'
Number of subjects: 251
Study 25679228 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention consisting of e‐bulletins
Number of subjects: 251
Study 23608658 — intervention group
Group type: COMPARATOR
Intervention: Sodium Repletion (SR)
Number of subjects: 64
Study 23608658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Depletion (SD)
Number of subjects: 64
Study 21126856 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotropic contractile reserve (ICR) assessed by low-dose dobutamine stress echocardiography
Number of subjects: 54
Study 21126856 — intervention group
Group type: COMPARATOR
Intervention: Dyssynchrony
Number of subjects: 54
Study 21126856 — intervention group
Group type: COMPARATOR
Intervention: QRS duration
Number of subjects: 54
Study 18068146 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 1092
Study 18068146 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 1092
Study 17203530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole
Number of subjects: 211
Study 17203530 — intervention group
Group type: COMPARATOR
Intervention: Oral omeprazole
Number of subjects: 211
Study 12717129 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study 12717129 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60
Study 10890580 — intervention group
Group type: EXPERIMENTAL
Intervention: Macorel tablets (test preparation)
Number of subjects: 18
Study 10890580 — intervention group
Group type: COMPARATOR
Intervention: Adalat tablets (reference preparation)
Number of subjects: 18
Study 8956918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) continued for 2 months
Number of subjects: 28
Study 8956918 — intervention group
Group type: COMPARATOR
Intervention: Placebo (VGB stopped for 3 weeks)
Number of subjects: 28
Study 8956918 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) continued
Number of subjects: 28
Study 8956918 — intervention group
Group type: COMPARATOR
Intervention: Placebo (VGB stopped)
Number of subjects: 28
Study 8040124 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B in 5% dextrose
Number of subjects: 42
Study 8040124 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B in Intralipid
Number of subjects: 42
Study 2742790 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group discussions
Number of subjects: 70
Study 2742790 — intervention group
Group type: COMPARATOR
Intervention: Large lecture group
Number of subjects: 70
Study 31064021 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial pivot (MP) implant
Number of subjects: 100
Study 31064021 — intervention group
Group type: COMPARATOR
Intervention: Posterior cruciate ligament (PCL) substitution (posterior‐stabilized [PS]) prosthesis
Number of subjects: 100
Study 31389278 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily rhythm of distal skin temperature (DST)
Number of subjects: 77
Study 31389278 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean DST during 10 consecutive hours of minimum values
Number of subjects: 77
Study 31389278 — intervention group
Group type: EXPERIMENTAL
Intervention: Interday stability of DST
Number of subjects: 77
Study 31389278 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraday variability of DST
Number of subjects: 77
Study 31389278 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to lowest ambient temperature
Number of subjects: 77
Study 28597102 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) + Weight Loss (WL)
Number of subjects: 36
Study 28597102 — intervention group
Group type: COMPARATOR
Intervention: Weight Loss (WL) alone
Number of subjects: 36
Study 25078334 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodalumab (antibody to interleukin-17 receptor A)
Number of subjects: 0
Study 23494471 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelsohn maneuver
Number of subjects: 18
Study 23494471 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18
Study 21755537 — intervention group
Group type: EXPERIMENTAL
Intervention: IPX066
Number of subjects: 27
Study 21755537 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa
Number of subjects: 27
Study 19284929 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychoeducation
Number of subjects: 120
Study 19284929 — intervention group
Group type: COMPARATOR
Intervention: Unstructured group support (Control)
Number of subjects: 120
Study 17539888 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h training programme in 'hands off' positioning and attachment support
Number of subjects: 135
Study 17539888 — intervention group
Group type: COMPARATOR
Intervention: Control group (student midwives)
Number of subjects: 135
Study 15121740 — intervention group
Group type: EXPERIMENTAL
Intervention: Young fit (YF)
Number of subjects: 40
Study 15121740 — intervention group
Group type: COMPARATOR
Intervention: Young unfit (YU)
Number of subjects: 40
Study 15121740 — intervention group
Group type: EXPERIMENTAL
Intervention: Older fit (OF)
Number of subjects: 40
Study 15121740 — intervention group
Group type: COMPARATOR
Intervention: Older unfit (OU)
Number of subjects: 40